Tuesday, April 3, 2012

Day 3 of Cushing's Awareness Challenge: Cushing's Patient Groups Get Fundraising Boost

I'm happy to report today's news from Corcept Therapeutics, the manufacturer of Korlym. This medication is the first FDA approved medication for the treatment of persistent Cushing's in the United States.

Corcept has shown great respect for the Cushing's community, including patient groups, bloggers, and yes, even Cushing's with Moxie.  They are responsive to ideas and feedback.  I am so happy to have a caring company on our side.  I was ecstatic to get the phone call about their project for Cushing's Awareness Day.

Support Cushing's ...with a Click.
Corcept Therapeutics will donate $5 for every person who clicks to support people with Cushing's. Corcept has jump-started the effort to build awareness and support with a $15,000 contribution to provide support through the Cushing's Support and Research Foundation and Cushing's Help. With your support, we can aim even higher!* Take part...and spread the word.

When:    now through April 20, 2012 

What:     Corcept Therapeutics will donate $5 for every click

For:       two Cushing's patient advocacy groups, Cushings-Help.com and Cushing’s Support and Research Foundation, will share all money raised. Corcept has promised a minimum of $15,000. 

Please be sure to share the link, and ask your friends and family to click, too.  

* ~ * ~ * ~ * ~ * ~ * ~ *

For more information on Korlym, visit these websites to see full safety and prescribing information, including boxed warning.

DISCLAIMER:  I participated in Corcept's market research study in February 2012. Corcept Therapeutics paid for my travel expenses. I flew to Philadelphia, where I gave feedback on marketing material and told my story on camera.  For that, I was received monetary compensation of $250. In addition, I am a Corcept stockholder.